Enzymatica: Funding, Investors & Team (Sep 2026)
Enzymatica is a life science company that specializes in providing effective solutions for common diseases caused by viruses or bacteria. In a short amount of time, they have created a unique oral spray for colds called ColdZyme® which has become a top-selling product in Swedish pharmacies. They also develop medical devices for upper respiratory infections, oral health, and veterinary products. Enzymatica is based in Lund, Sweden and is publicly traded on Nasdaq First North.
Enzymatica has raised $12.7M across 1 funding round on record, the most recent an undisclosed round of $12.7M announced in Sep 2024.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Enzymatica Company Profile and Key Stats
Latest funding round on record: Sep 2024.
Enzymatica Funding Rounds
Enzymatica Founders and Leadership Team
Contact details for the Enzymatica team: 1 of 1 has an email address on file.
Start 14-day free trial →Enzymatica Funding Compared to Other Health Care Startups
Enzymatica's latest round of $12.7M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enzymatica in Health Care and Lund
Companies Similar to Enzymatica
Neko Health, a health-tech company from Sweden, aims to develop a healthcare system that promotes the…
Celluminova specializes in the development of new tools for stem cell research, including cancer stem cells.
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative,…
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company’s founders have…
Spermosens is a medical equipment manufacturer that produces technologies for diagnosing male-factor…
IRLAB is a Swedish drug discovery and development company providing novel treatments for disorders of the…
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD, AD and…
Blodtrycksdoktorn is an evidence-based digital innovation that uses telemedicine, mobile health technology,…
B! BB Instruments develops an instrument that allows quick and easy sampling of suspected cancer tumors by…
Observe Medical has developed a revolutionary digital urine meter - Sippi. Sippi is an easy-to-use…
Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company…
Loovi is a health technology firm that provides a doctor-led, data-driven longevity solution. It focuses on…
Enzymatica Funding FAQs
What does Enzymatica do?
Enzymatica is a life science company that specializes in providing effective solutions for common diseases caused by viruses or bacteria. In a short amount of time, they have created a unique oral spray for colds called ColdZyme® which has become a top-selling product in Swedish pharmacies. They also develop medical devices for upper respiratory infections, oral health, and veterinary products. Enzymatica is based in Lund, Sweden and is publicly traded on Nasdaq First North.
How much funding has Enzymatica raised?
Enzymatica has raised $12.7M across 1 round on record. The most recent is an undisclosed round of $12.7M announced in Sep 2024.
When did Enzymatica last raise funding?
Enzymatica's most recent funding round on record is an undisclosed round of $12.7M, announced in Sep 2024.
Who founded Enzymatica?
FundedIQ lists Claus Egstrand (Founder) at Enzymatica.
Where is Enzymatica headquartered?
Enzymatica is based in Lund, Skane Lan, Sweden.
How many employees does Enzymatica have?
Enzymatica is in the 11-50 employee band.
How does Enzymatica's funding compare to other Health Care startups?
Enzymatica's latest round of $12.7M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Enzymatica Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enzymatica is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.